We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

15 hedge funds and large institutions have $2.31M invested in Altamira Therapeutics Ltd in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more capital invested

Capital invested by funds: $490K → $2.31M (+$1.82M)

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

88% more funds holding

Funds holding: 8 → 15 (+7)

41% more call options, than puts

Call options by funds: $365K | Put options by funds: $258K

Holders
15
Holders Change
+7
Holders Change %
+87.5%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
–
Closed
2
Calls
$365K
Puts
$258K
Net Calls
+$107K
Net Calls Change
+$107K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.55M
2
BFM
Boothbay Fund Management
New York
+$173K
3
Citadel Advisors
Citadel Advisors
Florida
+$119K
4
Simplex Trading
Simplex Trading
Illinois
+$73.7K
5
Morgan Stanley
Morgan Stanley
New York
+$44.2K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$167K
2
Renaissance Technologies
Renaissance Technologies
New York
-$165K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$1.6M +$1.55M +1,154 New
BFM
2
Boothbay Fund Management
New York
$180K +$173K +129 New
Citadel Advisors
3
Citadel Advisors
Florida
$159K +$119K +89 +356%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$75K – – –
Envestnet Asset Management
5
Envestnet Asset Management
Illinois
$69K +$25.5K +19 +61%
Morgan Stanley
6
Morgan Stanley
New York
$45K +$44.2K +33 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$44K +$42.9K +32 New
PAM
8
PVG Asset Management
Colorado
$37.5K +$36.2K +27 New
SFS
9
Sowell Financial Services
Arkansas
$24K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$19K +$18.8K +14 New
WAP
11
Wealthcare Advisory Partners
Pennsylvania
$17K +$17.4K +13 New
Osaic Holdings
12
Osaic Holdings
Arizona
$16K +$2.68K +2 +20%
Wells Fargo
13
Wells Fargo
California
$15K +$1.34K +1 +10%
Group One Trading
14
Group One Trading
Illinois
$3K +$2.68K +2 New
VF
15
Virtu Financial
New York
– -$167K -160 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$165K -158 Closed
Simplex Trading
17
Simplex Trading
Illinois
– +$73.7K +55 New

CYTO Hedge Fund Activity: Q1 2021 in Review

15 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q1 2021, worth a combined $2.31M — up 371% from $490K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CYTO positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.55M. The largest seller was Virtu Financial, exiting entirely with an estimated $167K sold.

  • 15 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q1 2021, up from 8 in Q4 2020.
  • Funds reported $2.31M of Altamira Therapeutics Ltd stock for Q1 2021, up 371% quarter-over-quarter.
  • 9 funds opened new Altamira Therapeutics Ltd positions in Q1 2021 and 2 closed out, a net change of +7 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q1 2021 was Ikarian Capital, an estimated $1.55M added.
  • The largest Altamira Therapeutics Ltd seller in Q1 2021 was Virtu Financial, an estimated $167K sold.

Based on aggregated 13F filings for Q1 2021.